• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GeoVax Labs Inc

+ Add to Watchlist


Price not available for E8LN:GR

Snapshot for GeoVax Labs Inc (E8LN)

Open: - Day's Range: - Volume: 0
Previous Close: 0.270 52wk Range: - 1-Yr Rtn: -

Stock Chart for E8LN

No chart data available.
  • E8LN:GR 0.270
  • 1M
  • 1Y
Interactive E8LN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for E8LN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 24.97
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for E8LN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for E8LN

GeoVax Labs Inc. is a biomedical company. The Company develops, manufactures, tests, conducts human trials, licenses, and commercializes human vaccines for diseases caused by HIV-1 (human immunodeficiency virus) [AIDS] and other infectious agents.

Robert T McNally "Bob"President/CEOMark W ReynoldsCFO/Secretary
Harriet L RobinsonChief Scientific Officer
More Company Profile & Key Executives for E8LN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil